BackCaliPharms Overview

CaliPharms Current Assets

Track CaliPharms's current assets ($17K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$17162.00
59079.31% YoYΔ $17133.00 vs prior year quarter

Peer trimmed avg / median

Loading

CaliPharms Current Assets History

Loading

CaliPharms vs. peers: Current Assets Comparison

Loading

CaliPharms Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

CaliPharms (KGET) FAQ

As of the most recent data (September 2014), KGET shows a current assets of $17K. That compares with $29 in the prior-year period — up 59079.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, KGET's current assets is now $17K (was $29) — a 59079.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether CaliPharms is outperforming or lagging.

Tracking KGET's current assets over time shows whether CaliPharms is scaling, shrinking, or reshaping that part of the business. The current reading is $17K That compares with $29 in the prior-year period — up 59079.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has CaliPharms's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $17K) with ownership activity and broader fundamentals.

CaliPharms's current assets is $17K; compare it with other Industrials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.